ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 2313 and H.R. 3697, the STAAR Act; S. 2278, Community and Healthcare Associated Infections Reduction Act; Issues relating to the implementation of Section 5001 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act, Section 2(b), Prior Authorization Programs; S. 1887, the Medicare Access to Critical Medications Act of 2007; H.R. 3061, the Medicare Part D Drug Class Protection Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL RUGGIERO New | — |
| SAMANTHA VENTIMIGLIA New | — |
Medicare/Medicaid MMM
S. 2313 and H.R. 3697, the STAAR Act; S. 2278, Community and Healthcare Associated Infections Reduction Act; Issues relating to the implementation of Section 5001 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act, Section 2(b), Prior Authorization Programs; S. 1887, the Medicare Access to Critical Medications Act of 2007; H.R. 3061, the Medicare Part D Drug Class Protection Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL RUGGIERO New | — |
| SAMANTHA VENTIMIGLIA New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTELLAS PHARMA, INC. | Japan | Japan | 99.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.